WNK2 somatic mutations and copy number loss were reported in hepatocellular carcinoma, resulting in lower WNK2 protein levels, which were associated with early tumor recurrence linked to enhanced ERK1/2 signaling [31]. This evidence concerns the gene WNK2 and hepatocellular carcinoma.